ÂÜÀòÂÒÂ×

Nancy brings more than 20 years of experience in the area of clinical operations management, providing consulting services to several pharmaceutical, biotech and medical device companies, with a specialization in the dermatology space. She has worked on Phase 1 through 4 studies encompassing small molecules, biologics, medical devices and combination products. Over the last three years she has been actively supporting Brickell’s clinical operations projects related to the sofpironium bromide (SB) clinical development program, starting with the Phase 2b study, the on-going long-term safety study and leading the planning and initiation of Phase 3 studies later this year. Nancy is leading the efforts for SB P3 clinical studies.